This inventor holds 2 USPTO granted patents. Top assignees: Rijksuniversiteit Groningen, Stichting Voor De Technische Wetenschappen. Active years: 2005-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 58 
2 out of 82 Years Active: 2005-2008
Title: Detlef Bruno Igor Schuppan: Innovator in Targeted Therapeutics
Introduction
Detlef Bruno Igor Schuppan is a notable inventor based in Bubenreuth, Germany. He has made significant contributions to the field of targeted therapeutics, particularly in the treatment of fibrotic and sclerotic diseases. With a total of 2 patents, his work focuses on innovative methods for targeting specific cells involved in these conditions.
Latest Patents
Schuppan's latest patents include a method for targeting cells involved in sclerotic and/or fibrotic diseases. This invention describes a compound that includes a carrier molecule linked to a cyclic peptide, which contains a sequence encoding a cell receptor recognizing peptide (RRP). The compound is designed to target Hepatic Stellate Cells (HSC) and is not a naturally occurring receptor agonist or antagonist. The RRP may include receptors such as PDGF, collagen type VI, and various cytokine receptors. The compounds are intended for use in pharmaceutical compositions aimed at treating diseases like lung fibrosis, rheumatoid arthritis, and sepsis.
Another significant patent by Schuppan involves peptide-based carrier devices for stellate cells. This invention also focuses on a compound comprising a carrier molecule linked to a cyclic peptide with an RRP specific for HSC. The compounds can be utilized in pharmaceutical compositions for therapy, prophylaxis, or diagnosis of fibrotic and sclerotic diseases.
Career Highlights
Throughout his career, Schuppan has worked with esteemed organizations such as Stichting voor de Technische Wetenschappen and Rijksuniversiteit Groningen. His research has contributed to advancements in the understanding and treatment of complex diseases.
Collaborations
Some of his notable coworkers include Eleonora Beljaars and Klaas Poelstra, who have collaborated with him on various research projects.
Conclusion
Detlef Bruno Igor Schuppan is a prominent inventor whose work in targeted therapeutics has the potential to significantly impact the treatment of fibrotic and sclerotic diseases. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile